1Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation.
2Quantitative Health Sciences, Cleveland Clinic Foundation; and.
J Neurosurg Spine. 2019 May 24;31(3):389-396. doi: 10.3171/2019.3.SPINE18419. Print 2019 Sep 1.
In 2009, 2 randomized controlled trials demonstrated no improvement in pain following vertebral augmentation compared with sham surgery. However, a recent randomized trial demonstrated significant pain relief in patients following vertebroplasty compared to controls treated with conservative medical management. This study is a retrospective review of prospectively collected patient-reported quality of life (QOL) outcomes. The authors hypothesized that vertebral augmentation procedures offer a QOL benefit, but that this benefit would be diminished in patients with a history of depression and/or in patients undergoing vertebral augmentation at more than 1 level.
Multivariable linear regression was used to identify predictors of postoperative pain assessed using the Pain Disability Questionnaire (PDQ), Patient Health Questionnaire 9 (PHQ-9), and EQ-5D scores. Eleven candidate predictors were selected a priori: age, sex, smoking history, coronary artery disease, depression, diabetes, procedure location (thoracic, lumbar), BMI, prior spine surgery, procedure indication (metastases, osteoporosis/osteopenia, other), and number of levels (1, 2, 3, or more).
A total of 143 patients were included in the study. For each 10-year increase in age, postoperative PDQ scores decreased (improved) by 9.7 points (p < 0.001). Patients with osteoporosis/osteopenia had significantly higher (worse) postoperative PDQ scores (+17.97, p = 0.028) than patients with metastatic lesions. Male sex was associated with higher (worse) postoperative PHQ-9 scores (+2.48, p = 0.010). Compared to single-level augmentation, operations at 2 levels were associated with significantly higher PHQ-9 scores (+2.58, p = 0.017). Current smokers had significantly lower PHQ-9 scores (-1.98, p = 0.023) than never smokers. No predictors were associated with significantly different EQ-5D score.
Variables associated with worse postoperative PDQ scores included younger age and osteoporosis/osteopenia. Variables associated with decreased (better) postoperative PHQ-9 scores included female sex, single operative vertebral level, and positive smoking status (i.e., current smoker). These clinically relevant predictors may permit identification of patients who may benefit from vertebral augmentation.
2009 年,两项随机对照试验表明,与假手术相比,椎体增强术并未改善疼痛。然而,最近的一项随机试验表明,与接受保守药物治疗的对照组相比,椎体成形术后患者的疼痛明显缓解。本研究是对前瞻性收集的患者报告生活质量(QOL)结果的回顾性分析。作者假设椎体增强术提供了 QOL 益处,但在有抑郁病史的患者和/或在超过 1 个水平进行椎体增强术的患者中,这种益处会降低。
使用多变量线性回归来确定使用疼痛残疾问卷(PDQ)、患者健康问卷 9(PHQ-9)和 EQ-5D 评分评估术后疼痛的预测因素。预先选择了 11 个候选预测因素:年龄、性别、吸烟史、冠状动脉疾病、抑郁、糖尿病、手术部位(胸椎、腰椎)、BMI、既往脊柱手术、手术指征(转移瘤、骨质疏松/骨量减少、其他)和手术节段数(1、2、3 或更多)。
共有 143 名患者纳入研究。年龄每增加 10 岁,术后 PDQ 评分降低(改善)9.7 分(p<0.001)。患有骨质疏松/骨量减少症的患者术后 PDQ 评分明显更高(更差)(+17.97,p=0.028),而患有转移瘤的患者则更高。男性的术后 PHQ-9 评分更高(更差)(+2.48,p=0.010)。与单节段增强相比,2 个节段的手术与 PHQ-9 评分显著升高(+2.58,p=0.017)相关。目前吸烟者的 PHQ-9 评分明显低于从不吸烟者(-1.98,p=0.023)。没有预测因素与 EQ-5D 评分显著不同。
与术后 PDQ 评分较差相关的变量包括年龄较小和骨质疏松/骨量减少。与术后 PHQ-9 评分降低(更好)相关的变量包括女性、单一手术椎体水平和阳性吸烟状态(即当前吸烟者)。这些具有临床意义的预测因素可能有助于识别可能受益于椎体增强术的患者。